IRLAB participates in Life Science Day in Gothenburg on March 4, 2026

Gothenburg, Sweden, March 2, 2026 – IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments for Parkinson’s disease, today announced that the company will participate in Life Science Day on Wednesday, March 4, 2026, in Gothenburg.

IRLAB secures milestone payment for first patient dosed in Phase Ib study with IRL757 in Parkinson’s Disease

IRLAB publishes full-year report for the period January – December 2025